Sectors
SANA
Sana Biotechnology, Inc.
3.87
2 x 2.76
2 x 4.88
bid
ask
-
0.06
1.53%
2 @ 05:46 PM
3.93 +0.06 (1.55%)
| Ytd | -4.91% | |
| 1y | 26.47% |
3.76
day range
3.90
2.61
52 week range
6.55
| Open | 3.87 | Prev Close | 3.93 | Low | 3.76 | High | 3.90 | Mkt Cap | 1.16B |
| Vol | 2.21M | Avg Vol | 3.11M | EPS | -0.75 | P/E | N/A | Forward P/E | -6.97 |
| Beta | 2.10 | Short Ratio | 17.24 | Inst. Own | 77.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 3.55 | 200-d Avg | 3.70 | 1yr Est | 8.43 |
| Income Statement | |||
| Operating Expenses | 65.42M | ||
| Research and Development Expense | 54.64M | ||
| Selling, General and Administrative Expense | 10.78M | ||
| Operating Income | -65.42M | ||
| Net Income | -63.63M | ||
| Net Income Common Stock | -63.63M | ||
| Net Income Common Stock (USD) | -63.63M | ||
| Consolidated Income | -63.63M | ||
| Earnings per Basic Share | -0.22 | ||
| Earnings per Basic Share (USD) | -0.22 | ||
| Earnings per Diluted Share | -0.22 | ||
| Earning Before Interest & Taxes (EBIT) | -63.63M | ||
| Earning Before Interest & Taxes (USD) | -63.63M | ||
| Weighted Average Shares | 295.67M | ||
| Weighted Average Shares Diluted | 295.67M | ||
| Balance Sheet | |||
| Cash and Equivalents | 61.27M | ||
| Cash and Equivalents (USD) | 61.27M | ||
| Investments | 103.42M | ||
| Investments Current | 103.42M | ||
| Current Assets | 170.63M | ||
| Property, Plant & Equipment Net | 60.52M | ||
| Total Assets | 431.52M | ||
| Debt Current | 14.51M | ||
| Total Debt | 73.74M | ||
| Current Liabilities | 123.75M | ||
| Debt Non-Current | 59.23M | ||
| Total Liabilities | 276.95M | ||
| Accumulated Retained Earnings (Deficit) | -1.96B | ||
| Accumulated Other Comprehensive Income | -66.00K | ||
| Shareholders Equity | 154.57M | ||
| Shareholders Equity (USD) | 154.57M | ||
| Assets Non-Current | 260.89M | ||
| Total Debt (USD) | 73.74M | ||
| Goodwill and Intangible Assets | 199.82M | ||
| Liabilities Non-Current | 153.20M | ||
| Trade and Non-Trade Payables | 1.36M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.72M | ||
| Net Cash Flow from Financing | 93.58M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -26.73M | ||
| Capital Expenditure | -1.60M | ||
| Issuance (Purchase) of Equity Shares | 93.68M | ||
| Issuance (Repayment) of Debt Securities | -93.00K | ||
| Net Cash Flow from Investing | -87.52M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -85.92M | ||
| Net Cash Flow from Operations | -32.79M | ||
| Share Based Compensation | 5.34M | ||